Implementation costs of skin infection surveillance in the Kimberley: learnings from the SToP Trial
Background The SToP (See, Treat, Prevent) Trial implemented a skin-control program to reduce impetigo in remote Kimberley Aboriginal communities. We aimed to estimate the cost of conducting the school-based skin screening component of the SToP Trial and estimate the annual costs of two feasible service delivery approaches for ongoing screening in remote Aboriginal communities: an Outreach approach and a Community-Owned approach delivered by a local school-based health workforce. Methods A retrospective micro-costing of skin screening trips (2019; 2022) to nine communities was conducted from a healthcare provider perspective. Year-specific costs were inflation-adjusted to 2024 Australian Dollars (AUD) and reported per trip and per child. One-way sensitivity analyses and scenario-based cost estimates were used to compare Outreach and Community-Owned approaches. Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12618000520235. Results Mean cost per trip in 2024 AUD decreased 16.6%, from $159,928 (2019) to $133,354 (2022); cost per child for screening in 2019 and 2022 was $445 and $478, respectively as fewer children were screened in 2022 due to COVID-19 disruptions. In 2022, costs were dominated by fixed costs, primarily staff costs (60.5% of total). Annual estimated costs were $210,666 for Outreach, $183,287 for Community-Owned delivery led by an Aboriginal Health Worker and $260,223 for Community-Owned delivery led by a school health nurse. Conclusions School-based skin screening has predictable, staffing-dominated costs. Estimated costs varied by staffing configuration, with Community-Owned delivery led by an Aboriginal Health Worker having the lowest annual cost. Community-Owned delivery was preferred by consulted stakeholders, although this study did not assess cost-effectiveness or comparative clinical outcomes. These costings can guide implementation and scale-up of culturally responsive skin screening programs to reduce skin infection burden and their resulting complications in remote Aboriginal communities.
Authors
- Judith Masha Katzenellenbogen (ORCID: https://orcid.org/0000-0001-5287-5819)
- Lorraine Anderson (ORCID: https://orcid.org/0000-0003-0239-2987)
- Jeffrey W. Cannon (ORCID: https://orcid.org/0000-0002-1321-9605)
- Kate Maddams
- Ingrid Stacey (ORCID: https://orcid.org/0000-0002-3032-6031)
- Marianne J. Mullane
- Asha C Bowen (ORCID: https://orcid.org/0000-0002-3242-1155)
- Stephanie Enkel (ORCID: https://orcid.org/0000-0003-4075-0781)
- Hannah M.M. Thomas (ORCID: https://orcid.org/0000-0003-3699-7714)
- On behalf of The SToP (See, Treat, Prevent) Skin Sores and Scabies Trial
- Jules Custodio
Institutions
- The Kids Research Institute Australia (AU)
- The University of Western Australia (AU)
- Victor Chang Cardiac Research Institute (AU)
- Princess Margaret Hospital for Children (AU)
- WA Country Health Service (AU)
- Environs Kimberley (AU)
- Kimberley Aboriginal Medical Services (AU)
- Perth Children's Hospital (AU)
Publication Details
- Journal
- Archives of Dermatological Research
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s00403-026-05042-3
- Primary Topic
- Indigenous Health, Education, and Rights
- Type
- article
- Field-Weighted Citation Impact
- 0.00